Sales Nexus CRM

SS Innovations Launches Sri Lanka's First Robotic Cardiac Surgery Program with SSi Mantra 3.0

By FisherVista
SS Innovations International Inc. has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using its SSi Mantra 3.0 system, marking a significant expansion of robotic surgery in the region and highlighting the company's growing global footprint.
SS Innovations Launches Sri Lanka's First Robotic Cardiac Surgery Program with SSi Mantra 3.0

SS Innovations International Inc. (NASDAQ: SSII) has brought robotic cardiac surgery to Sri Lanka with the launch of the country's first robotic cardiac surgery program at Kings Hospital Colombo. The program uses the company's SSi Mantra 3.0 surgical robotic system and represents a significant step in the adoption of advanced surgical technology in the region.

The program began with a robotic-assisted left internal mammary artery (LIMA) takedown, performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. This initial procedure marks the first time robotic technology has been used for cardiac surgery in Sri Lanka, potentially improving patient outcomes through minimally invasive techniques.

According to a recent company video describing the program's early activity, Kings Hospital has completed more than 25 robotic procedures in just three weeks. This rapid uptake demonstrates the potential for robotic surgery to become a standard part of cardiac care in Sri Lanka and beyond.

SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter. The company's second-quarter revenue reached $13.9 million, while robotic procedures increased 143% year over year to 2,528. These figures point to rising utilization of the company's installed base and growing demand for its surgical robotic systems.

The next major corporate milestone for SS Innovations is regulatory expansion, with the company pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system. Achieving these certifications would allow SS Innovations to enter two of the largest medical device markets in the world, potentially accelerating its growth and expanding access to robotic surgery for patients globally.

The launch of Sri Lanka's first robotic cardiac surgery program is important because it signals the continued globalization of robotic-assisted surgery, which can lead to smaller incisions, reduced pain, and faster recovery times for patients. For the medical device industry, it highlights the increasing competition and innovation in the surgical robotics space, where companies like SS Innovations are challenging established players.

For investors, the news underscores SS Innovations' progress in expanding its global footprint and driving procedure growth. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.

TechMediaWire, a specialized communications platform focused on pioneering companies driving the future of technology, distributes news for SS Innovations. More information about TechMediaWire is available at https://www.TechMediaWire.com. The full terms of use and disclaimers applicable to all content provided by TechMediaWire are available at https://www.TechMediaWire.com/Disclaimer.

FisherVista

FisherVista

@fishervista